Ren Hong Tang
Direktor/Vorstandsmitglied bei SIMCERE PHARMACEUTICAL GROUP LIMITED
Vermögen: 3 Mio $ am 31.05.2024
Profil
Ren Hong Tang is currently an Executive Director at Simcere Pharmaceutical Group Ltd.
and an Executive Director at Jiangsu Simcere Pharmaceutical Co., Ltd.
Previously, he held positions as the Chairman & General Manager at Jiangsu Simcere Medical Diagnostics Co., Ltd., Associate Director-China Innovation Center at AstraZeneca Investment (China) Co. Ltd., Director at 3D Medicines, Inc., and Vice General Manager at Shanghai Shengdi Pharmaceutical Co., Ltd.
He obtained a doctorate degree from Nanyang Technological University in 2007 and an undergraduate degree from Shanghai Jiao Tong University in 2002.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.11.2023 | 3 650 000 ( 0,14% ) | 3 Mio $ | 31.05.2024 |
Aktive Positionen von Ren Hong Tang
| Unternehmen | Position | Beginn |
|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Direktor/Vorstandsmitglied | 01.11.2019 |
Jiangsu Simcere Pharmaceutical Co., Ltd.
 Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ren Hong Tang
| Unternehmen | Position | Ende |
|---|---|---|
| Shanghai Shengdi Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 01.05.2019 |
| AstraZeneca Investment (China) Co. Ltd. | Corporate Officer/Principal | 01.08.2017 |
Jiangsu Simcere Medical Diagnostics Co., Ltd.
 Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang. | Vorstandsvorsitzender | - |
| 3D MEDICINES INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Ren Hong Tang
| Shanghai Jiao Tong University | Undergraduate Degree |
| Nanyang Technological University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
| 3D MEDICINES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Shanghai Shengdi Pharmaceutical Co., Ltd. | |
| AstraZeneca Investment (China) Co. Ltd. | |
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Health Technology |
Jiangsu Simcere Medical Diagnostics Co., Ltd.
Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang. | Health Technology |
